Rituximab News
International Approvals: NuvaRing, MabThera, Gemzar
Australia's Therapeutic Goods Administration has approved a once-monthly etonogestrel/ethinyl estradiol vaginal ring for contraceptive use in women; the European Commission has approved a new indication for rituximab injection,...
Rituximab is granted EU approval as maintenance therapy for NHL
The European Commission has approved the use of the drug rituximab as a maintenance therapy for people with follicular non-Hodgkin's lymphoma (NHL) that has relapsed or not responded to previous treatment.
EU Approves Roche Top-Selling Cancer Drug For Arthritis
Zurich, Switzerland (AHN) - Swiss drug maker, Roche, said on Tuesday that the European Commission had approved its drug MabThera, a cancer-drug, to treat lymphoma patients with arthritis.
Roche's MabThera gets new EU lymphoma OK
The European Commission has approved Roche's MabThera as maintenance therapy for patients with relapsed or refractory follicular non-Hodgkin's lymphoma, a common form of lymphoma.
Roche's Mabthera receives EU approval for rheumatoid arthritis, NHL
The drug has been indicated as a combination treatment for adults with severe active rheumatoid arthritis, who have had an inadequate response or are intolerant to current treatment options, the Swiss pharma group said.